# Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

> **NCT02551731** · PHASE2 · TERMINATED · sponsor: **INSYS Therapeutics Inc** · enrollment: 9 (actual)

## Conditions studied

- Spasms, Infantile

## Interventions

- **DRUG:** Cannabidiol Oral Solution

## Key facts

- **NCT ID:** NCT02551731
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01-27
- **Primary completion:** 2016-09-06
- **Final completion:** 2016-09-06
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Sponsor elected not to continue with study
- **Last updated:** 2018-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02551731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02551731, "Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02551731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*